Where this LCD applies
Each contract number is a jurisdiction on the remittance; the policy binds claims processed under these contracts and no others.
| Contract | Contractor | Type | States |
|---|---|---|---|
| 15102 | CGS Administrators, LLC | MAC - Part B | KY |
| 15202 | CGS Administrators, LLC | MAC - Part B | OH |
| 15101 | CGS Administrators, LLC | MAC - Part A | KY |
| 15201 | CGS Administrators, LLC | MAC - Part A | OH |
Billing and coding article A56697: diagnoses and procedure codes
Since 2019 the codes live in the companion article rather than the LCD. Billing and Coding A56697 (Billing and Coding: Non-Invasive Vascular Studies) carries the diagnosis and procedure lists the contractor loads as the claims edit. CPT codes are shown as bare numbers because the descriptors are licensed by the AMA; HCPCS Level II descriptors are public and shown. Each article below opens its complete covered and non-covered ICD-10-CM lists, by group and with the contractor's group instructions, and the LCD code lookup answers whether one diagnosis is covered for one procedure code in a given state.
Coverage is only half of the claim edit: when two of the listed procedure codes are billed on the same date, test the pair against the NCCI edits before relying on both being paid.
A56697: Billing and Coding: Non-Invasive Vascular Studies (Billing and Coding, effective 2026-11-05)
- Covered ICD-10-CM codes
- 1440
- 8 groups
- Non-covered ICD-10-CM codes
- 0
- Procedure codes listed
- 22
- Full article
- cms.gov record
| ICD-10-CM | Description (FY2027) |
|---|---|
| A48.0 | Gas gangrene |
| C22.0 | Liver cell carcinoma |
| C22.1 | Intrahepatic bile duct carcinoma |
| C22.2 | Hepatoblastoma |
| C22.3 | Angiosarcoma of liver |
| C22.4 | Other sarcomas of liver |
| C22.7 | Other specified carcinomas of liver |
| D56.0 | Alpha thalassemia |
| D56.1 | Beta thalassemia |
| D56.2 | Delta-beta thalassemia |
| D56.3 | Thalassemia minor |
| D56.5 | Hemoglobin E-beta thalassemia |
| D56.9 | Thalassemia, unspecified |
| D57.01 | Hb-SS disease with acute chest syndrome |
| D57.02 | Hb-SS disease with splenic sequestration |
| D57.03 | Hb-SS disease with cerebral vascular involvement |
| D57.04 | Hb-SS disease with dactylitis |
| D57.09 | Hb-SS disease with crisis with other specified complication |
| D57.1 | Sickle-cell disease without crisis |
| D57.40 | Sickle-cell thalassemia without crisis |
| D57.411 | Sickle-cell thalassemia, unspecified, with acute chest syndrome |
| D57.412 | Sickle-cell thalassemia, unspecified, with splenic sequestration |
| D57.414 | Sickle-cell thalassemia, unspecified, with dactylitis |
| D57.431 | Sickle-cell thalassemia beta zero with acute chest syndrome |
Procedure codes: 93880, 93882, 93886, 93888, 93892, 93893, 93922, 93923, 93924, 93925, 93926, 93930, 93931, 93970, 93971, 93975, 93976, 93978, 93979, 93985, 93986, 93990.
Coverage indications, limitations and medical necessity
Abstract:
Non-invasive vascular studies utilize ultrasonic Doppler and physiologic principles to assess irregularities in blood flow in arterial and venous systems. The display may be a two dimensional image with spectral analysis and color flow or a plethysmographic recording. For the purposes of this policy, non-invasive vascular studies include duplex scans, physiologic studies and plethysmography.
Definitions:
Duplex scan: An ultrasonic scanning procedure with display of both two-dimensional structure and motion with time and Doppler ultrasonic signal documentation with spectrum analysis and/or color flow velocity mapping or imaging.
Physiologic studies: Functional measurement procedures that include Doppler ultrasound studies, blood pressure measurements, transcutaneous oxygen tension measurement, or plethysmography.
Plethysmography: Plethysmography involves the measurement and recording (by one of several methods) of changes in the size of a body part as modified by the circulation of blood in that part. Plethysmography is of value as a noninvasive technique for diagnostic, preoperative and postoperative evaluation of peripheral artery disease in the internal medicine or vascular surgery practice. It is also a useful tool for the preoperative podiatric evaluation of the diabetic patient or one who has intermittent claudication or other signs or symptoms indicative of peripheral vascular disease which have a bearing on the patient’s candidacy for foot surgery. (CMS Publication 100-03, Medicare National Coverage Decisions Manual , Chapter 1, Section 20.14)
Transcranial Doppler: Pulsed Doppler ultrasound is used to interrogate the intracranial vasculature of the Circle of Willis. Its value has been established in detecting severe stenosis in the major intracranial arteries, assessing patterns and extent of collateral circulation in patients with known regions of severe stenosis or occlusion and evaluating and following patients with vasoconstriction particularly after subarachnoid hemorrhage.
This local coverage determination specifies CGS policy for non-invasive vascular study testing.
INDICATIONS AND LIMITATIONS:
General Indications:
Non-invasive vascular studies are considered medically necessary if the ordering physician has reasonable expectation that their outcomes will potentially impact the clinical management of the patient. Services are deemed medically necessary when the following conditions are met:
• Significant signs/symptoms of arterial or venous disease are present;
• The information is necessary for appropriate medical and/or surgical management; and/or
• The test is not redundant of other diagnostic procedures that must be performed.
In general, non-invasive studies of the arterial system are utilized when invasive correction is contemplated. It is the responsibility of the physician/provider to ensure the medical necessity of procedures and documentation of such in the medical record.
Credentialing and Accreditation Standards
The accuracy of non-invasive vascular diagnostic studies depends on the knowledge, skill, and experience of the technologist and interpreter. Consequently, the physician performing and/or interpreting the study must be capable of demonstrating documented training and experience and maintain any applicable documentation. A vascular diagnostic study may be personally performed by a physician or a technologist.
The GAO Report to Congressional Committees entitled Medicare Ultrasound Procedures. Consideration of Payment Reforms and Technician Qualifications Requirements states that “Findings from several peer-reviewed studies, the Medicare Payment Advisory Commission, and ultrasound-related professional organizations support requiring that sonographers either have credentials or operate in facilities that are accredited, where specific quality standards apply. In some localities and practice settings, CMS or its contractors have required that sonographers either be credentialed or work in an accredited facility.” (GAO-07-734)
For areas under CGS Administrators, LLC jurisdiction the requirements will be effective for all providers 30 April 2011:
• All non-invasive vascular diagnostic studies must be performed under at least one of the following settings: (1) performed by a physician who is competent in diagnostic vascular studies or under the general supervision of physicians who have demonstrated minimum entry level competency by being credentialed in vascular technology, or (2) performed by a technician who is certified in vascular technology, or (3) performed in facilities with laboratories accredited in vascular technology.
• Examples of appropriate personnel certification include, but are not limited to the Registered Physician in Vascular Interpretation (RPVI), Registered Vascular Technologist (RVT), the Registered Cardiovascular Technologist (RCVT), Registered Vascular Specialist (RVS), and the American Registry of Radiologic Technologists (ARRT) credentials in vascular sonography. Appropriate laboratory accreditation includes the American College of Radiology (ACR) Vascular Ultrasound Program, and the Intersocietal Commission for the Accreditation of Vascular Laboratories (ICAVL).
• Additionally, transcutaneous oxygen tension measurements may be performed by individuals possessing the following credentials obtained from the National Board of Diving and Hyperbaric Medicine Technology (NBDHMT): Certified Hyperbaric Technologist (CHT), or Certified Hyperbaric Registered Nurse (CHRN).
Please Note: 42 CFR Section 410.33, Independent Diagnostic Testing Facilities, includes credentialing requirements that supersede those above:
The supervising physician must evidence proficiency in the performance and interpretation of each type of diagnostic procedure performed by the IDTF. The proficiency may be documented by certification in specific medical specialties or subspecialties or by criteria established by the carrier for the service area in which the IDTF is located. See 42 CFR Section 410-33 (2) (b).
Nonphysician personnel: Any nonphysician personnel used by the IDTF to perform tests must demonstrate the basic qualifications to perform the tests in question and have training and proficiency as evidenced by licensure or certification by the appropriate State health or education department. In the absence of a State licensing board, the technician must be certified by an appropriate national credentialing body. The IDTF must maintain documentation available for review that these requirements are met. See 42 CFR Section 410-33 (2)(c).
General Limitations:
A referral must be on record for each non-invasive study performed. A referral for one type of study does not qualify as a referral for all tests.
Non-invasive vascular studies are considered medically necessary only if the outcome will potentially impact the clinical course of the patient. For example, if a patient is (or is not) proceeding on to other diagnostic and/or therapeutic procedures regardless of the outcome of non-invasive studies, and non-invasive vascular procedures will not provide any unique diagnostic information that would impact patient management, then the non-invasive procedures are not medically necessary. If it is obvious from the findings of the history and physical examination that the patient is going to proceed to angiography, then non-invasive vascular studies are not medically necessary.
Non-invasive vascular studies include patient care required to perform the studies, supervision of the studies, and interpretation of study results with hard copy output or imaging. Digital storage of imaging is acceptable.
The use of any Doppler device that produces a record that does not permit analysis of bidirectional vascular flow or that does not provide a hard copy printout is part of the physical exam of the vascular system and is not reported separately. ( CPT Expert , 2004, 4th Edition)
The performance of simultaneous arterial and venous studies during the same encounter should be rare. Documentation should be available to support the medical necessity for both studies.
It is rarely necessary to perform cerebrovascular and upper extremity studies on the same day. Documentation supporting the need for both studies should be available for review.
Medicare does not pay for routine screening tests. ICD-10-CM diagnosis code Z13.9 (Special screening of other conditions, unspecified condition) should be used to indicate screening tests performed in the absence of a specific sign, symptom, or complaint. Use of ICD-10-CM code Z13.9 will result in the denial of claims as non-covered screening services.
I. Cerebrovascular Arterial Studies
Extracranial Arterial Studies (93880 - 93882)
Covered cerebrovascular arterial study testing methods include (real-time) duplex scans; and Doppler ultrasound waveform with spectral analysis.
Non-covered/non-reimbursed methods include testing methods that have not been found to be useful based on authoritative technological assessments or that are included as part of the physical examination.
Indications:
Cerebrovascular arterial studies may be considered medically necessary if one or more of the following signs and symptoms are present:
• Asymptomatic or symptomatic cervical bruits;
• Amaurosis fugax;
• Focal cerebral or ocular transient ischemic attacks (including but not limited to):
• localizing symptoms, e.g., sensory loss; and/or
• weakness of one side of the face; and/or
• slurred speech; and/or
• weakness of a limb;
• Syncope that is strongly suggestive of vertebrobasilar or bilateral carotid artery disease in etiology, as suggested by medical history;
• Recent history of a previous neurologic or cerebrovascular event;
• Before major cardiac and vascular surgery when a bruit is noted or there is a history of previous neurologic or cerebrovascular event;
• After carotid endarterectomy (outside the global period), or follow-up of previously documented stenoses;
• Pulsatile neck mass;
• Evaluation of blunt or penetrating neck trauma;
• Ocular microembolism (optic nerve/retinal arterial-Hollenhorst plaques/ocular);
• Arterial Fibromuscular dysplasia
Limitations: Studies may not be considered medically necessary if performed for the following signs and symptoms:
• Drop attack or syncope are rare indications usually seen with vertebrobasilar or bilateral carotid artery disease.
• Dizziness is not a typical indication unless associated with other localizing signs or symptoms. However, episodic dizziness with symptom characteristics typical of transient ischemic attacks may indicate medical necessity, especially when other more common sources, e.g., postural hypotension or transiently decreased cardiac output as demonstrated by cardiac event monitoring, have been previously excluded; and/or
• Headaches (including migraines).
Duplex ultrasonography has gained an acceptable role in the diagnosis and management of fibromuscular dysplasia. An international consensus document on the diagnosis and management of fibromuscular dysplasia states the first step to confirm clinical suspicion of renal FMD is non-invasive imaging with CTA as the initial test preferred and MRA if CTA is contraindicated. (Gornik 2019)
A European consensus document on the diagnosis and management of fibromuscular dysplasia recommends noninvasive studies in the following scenarios(Persu 2014):
• Duplex ultrasound should be first-line screening test to detect RAS and confirmed by another imaging technique if positive result or if negative result accompanied by high clinical suspicion.
• MR-angiography or CT-angiography are considered first line tests and should be used to confirm diagnosis of renal artery FMD in the following cases
• Results of DUS are suboptimal
• Degree of suspicion of FMD is high and/or
• FMD diagnosis would have major clinical implications.
The American Heart Association published a statement acknowledging the role noninvasive imaging studies such as duplex ultrasonography, CTA, and MRA, with the gold standard as catheter-based angiography as a diagnostic path for renal FMD. (Olin 2014)
Transcranial Doppler (TCD) Studies (93886 – 93893)
Transcranial Doppler (TCD) studies of the intracranial arteries and transcranial duplex imaging of extracranial arteries are approved methods of testing. The presence, location, and extent of disease can be evaluated by utilizing directional pulsed Doppler to estimate flow velocities and assess intracranial vessel hemodynamics and physiology.
Indications:
TCD studies are allowed for the following:
• Detection and evaluation of the hemodynamic effects of severe stenosis or occlusion of the extracranial (greater than or equal to 60% diameter reduction) and major basal intracranial arteries (greater than or equal to 50% diameter reduction);
• Detection and serial evaluation of cerebral vasospasm complicating subarachnoid hemorrhage;
• Evaluation of intracranial hemodynamic abnormalities in patients with suspected brain death;
• Intraoperative and perioperative monitoring of intracranial flow velocity and hemodynamic patterns during carotid endarterectomy, (although the professional component could only be reimbursed if it is provided during the operative procedure by a physician that is not a member of the operating team);
• Evaluation of cerebral embolization; and/or
• Assessing hemodynamic effects, patterns, and extent of collateral circulation in patients with known regions of severe stenosis or occlusion when necessary to care for the patient; and
• Assessing stroke risk in children aged two to sixteen with homozygous sickle cell disease; and
• As an alternative to an echocardiogram to detect residual right to left shunting after repair/closure of an intracardiac or intrapulmonary shunt.
Multiple cerebrovascular procedures may be allowed during the same encounter given the physician/provider can demonstrate medical necessity as documented in the patient’s medical record. For example, physiologic studies and a duplex scan are allowed on the same date of service given the provider is able to document medical necessity, e.g., greater than or equal to 50% stenosis on duplex scan or significant symptoms as demonstrated by the indications for the study.
Limitations:
TCD studies are not indicated for:
• Evaluation of brain tumors;
• Assessment of familial and degenerative disease of the cerebrum, brainstem, cerebellum, basal ganglia and motor neurons;
• Evaluation of infectious and inflammatory conditions;
• Psychiatric disorders; and/or
• Epilepsy.
Transcranial Doppler (TCD) is considered investigational and not medically necessary for the following indications:
• Assessing patients with migraine;
• Monitoring during cardiopulmonary bypass and other cerebrovascular and cardiovascular interventions, and surgical procedures (except during carotid endarterectomy, as noted above);
• Evaluation of patients with dilated vasculopathies such as fusiform aneurysms;
The policy text continues in the CMS record.
Summary of evidence (opening)
N/A
the full summary and analysis of evidence are in the CMS record.
Dates, lineage and related policies
- Original determination effective
- 2015-10-01
- Current revision effective
- 2026-11-05
- Last reviewed by the contractor
- 2026-10-20
- MCD version
- 39
- Derived from
- L31841
The contractor lists 3 National Coverage Determinations as related: NCD 20.14 Plethysmography, NCD 20.17 Noninvasive Tests of Carotid Function, NCD 220.11 Thermography. Where an NCD speaks, it controls; the LCD can only address what the NCD leaves open.
Other related documents: A60198 (Response to Comments).
Using this policy on a claim
Match the documented indication to the covered indications above before the service is scheduled, carry a diagnosis from the article's covered list on the claim line (the diagnosis coverage checker tests one code pair against every article that applies in a state), and keep the elements the documentation section asks for in the record, because the contractor can request it later through medical review. A denial under this policy arrives as CARC 50 with remark N115; the LCD lookup guide walks through the appeal path and the Advance Beneficiary Notice rules, and the CGS Administrators, LLC hub lists every other active policy from the same contractor.
The same policy title at other contractors
Contractors often adopt each other's policies and then revise them separately, so the criteria and the diagnosis lists drift apart. The topic comparison lines up every version.
For teams evaluating QuickIntell software
Where QuickIntell fits with this policy
If your team repeatedly reviews local coverage policies, explore QuickAuth for requirement checks, documentation and status tracking with staff oversight. Confirm the applicable policy, supported workflow and review responsibilities. Use QuickRCM to evaluate the separate claim and denial workflow.
Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.
Frequently asked questions
What does LCD L34045 cover?
Non-invasive vascular studies utilize ultrasonic Doppler and physiologic principles to assess irregularities in blood flow in arterial and venous systems. The display may be a two dimensional image with spectral analysis and color flow or a plethysmographic recording. For the purposes of this policy, non-invasive vascular studies include duplex scans, physiologic studies and plethysmography. The full 2,099-word policy text is reproduced below from the Medicare Coverage Database export of November 12, 2026.
Which states does LCD L34045 apply to?
CGS Administrators, LLC applies it to Medicare claims in 2 states: KY, OH. It binds only that contractor; 1 other contractor version of this title governs other jurisdictions, and elsewhere the same service is judged under the local contractor's own policy or, where none exists, claim by claim.
Which diagnosis codes support medical necessity under LCD L34045?
The companion billing and coding article A56697 lists 1,440 ICD-10-CM codes in 8 groups that support medical necessity; the first 24 appear on this page, where the complete list opens by group with the contractor's group instructions.
How do I appeal a denial under LCD L34045?
A denial under LCD L34045 carries claim adjustment reason code 50 with remark code N115. Compare the documented indication with the policy's covered indications and article A56697's 1,440 covered diagnosis codes, then file a redetermination with CGS Administrators, LLC within 120 days, record attached. If the service falls outside the policy, bill the patient only with a valid Advance Beneficiary Notice signed before the service.
Sources
Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.
- Medicare Coverage Database, current LCD exportVersion MCD release 2026-11-12 · effective 2026-11-08 · file lcd.csvSHA-256 2e0eda3351aa3d47…
- Medicare Coverage Database, current Billing and Coding Articles exportVersion MCD release 2026-11-12 · effective 2026-11-08 · file article.csvSHA-256 b475751458564786…
- ICD-10-CM FY2027 code descriptionsVersion FY2027 · effective 2026-10-01 · file icd10cm_codes_2027.txtSHA-256 3c0583a38ee0e848…
Disclaimer
The policy text and code lists are reproduced from the CMS Medicare Coverage Database export as an operational reference. Verify against the current LCD and article on cms.gov before billing; coverage depends on the full record and the contractor. Not legal, clinical or billing advice.
Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.